Month: January 2025

Form 8.3 – [LOUNGERS PLC – 27 01 2025] – (CGWL)

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LOUNGERS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 27 01 2025] – (CGWL)

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its portfolio of proprietary assets to clinic.NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 28, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today is pleased to announce the completion of the first phase of its strategic collaboration with Sarborg Limited. This partnership was initiated in December 2024 to integrate an advanced artificial intelligence and cybernetics technology (“AI”) into the Company’s operations, marking a transformative step in how Conduit would develop and deliver drug development. By leveraging AI, the Company is seeking to streamline drug repurposing, accelerate...

Auction of Treasury Bills on 30 January 2025

Written by Customer Service on January 28, 2025. Posted in Public Companies.

The treasury bills for sale have the following stock exchange codes: Name Stock exchange code MaturityDGTB 03/03/25 25 / I 98-19740 3 March 2025DGTB 02/06/25 25 / II 98-19823 2 June 2025The sale will settle on 3 February 2025 at the stop-rate for each serie. In case of bid on stop-rate a pro-rata ratio may occur. The deadline for bidding is 10.15 on the day of the auction.

Elanders AB: Year-end Report 2024

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Full year 2024Net sales increased to MSEK 14,143 (13,867), which corresponded to an organic net sales reduction of two percent, excluding acquisitions and discontinued operations, and using unchanged exchange rates. Adjusted EBITA amounted to MSEK 879 (927), which equaled an adjusted EBITA margin of 6.2 (6.7) percent. Operating profit was impacted by one-off items of MSEK 14 (-107), which mainly referred to revaluation of an additional consideration for an acquisition, structural measures in China, Germany, the UK and the USA, as well as acquisition costs. Adjusted net result amounted to MSEK 143 (349), corresponding to SEK 3.85 (9.60) per share. Operating cash flow adjusted for purchase prices for acquisitions amounted to MSEK 1,978 (2,170). Operating cash flow including acquisitions amounted to MSEK 894 (1,338). Cash conversion...

Cornish Metals Inc: Strategic Investment and Proposed Fundraising of a minimum of £56 million

Written by Customer Service on January 28, 2025. Posted in Public Companies.

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, SINGAPORE, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE A PROSPECTUS OR OFFERING MEMORANDUM OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF CORNISH METALS INC. OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION...

ProductLife Group Acquires Stragen Services, Strengthening Pharmacovigilance and Clinical Safety Expertise Within the European Market

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

PARIS, Jan. 28, 2025 (GLOBE NEWSWIRE) — ProductLife Group (PLG), a global provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry, is pleased to announce the acquisition of Stragen Services, a division of Stragen Group, a well-established European Specialty Generics platform backed by healthcare-focused global private equity firm ARCHIMED. Founded in 2009 and located in Lyon, France, Stragen Services is a recognized partner to the Pharma and Biotech communities in the fields of Pharmacovigilance and Clinical Safety services. With a team of 36 employees, Stragen Services has earned a reputation for its strong expertise and tailored pharmacovigilance support services. By bringing Stragen Services into the PLG fold, the Group will expand in these critical areas,...

Treatment.com AI Enters Into a Binding Letter of Intent to Acquire Alea Health Holdings Limited adding an AI Powered Voice Agent and Mental Health to its Platform

Written by Customer Service on January 28, 2025. Posted in Public Companies.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESStrategic Expansion with Proposed Acquisition of Alea Health Holdings Limited, a UAE based AI company‏ Proprietary Voice Agent using Conversational AI for onboarding and triaging patients‏ Extended geographic reach – entry into the Middle East Healthcare market‏ Advancing Mental Health Support using Alea’s proprietary and AI powered Mental Health Platform to Augment Primary and Specialist Care‏ Enhanced Bench Strength: Expertise Driving InnovationVANCOUVER, British Columbia, Jan. 28, 2025 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“‏‏Treatment‏‏”) is pleased to announce it has entered into a binding letter of intent dated January 28, 2025 (the “‏‏Letter of Intent‏‏”) with Alea...

21Shares Adds to its “Core” Suite of Affordable Crypto Exchange-Traded Products with the Launch of the Solana Core Staking ETP (CSOL)

Written by Customer Service on January 28, 2025. Posted in Public Companies.

ZURICH, 28 January 2025 – 21Shares AG (“21Shares”), one of the world’s largest issuers of crypto exchange traded products (ETPs), today announced the launch of the 21Shares Solana Core Staking ETP (CSOL) on SIX Swiss Exchange. CSOL joins the 21Shares Bitcoin Core ETP (CBTC), the 21Shares Ethereum Core Staking ETP (ETHC) and the 21Shares Crypto Basket 10 Core ETP (HOLDX) as the fourth addition to the 21Shares’ “core” suite, which offers investors exposure to cutting-edge crypto technologies at exceptionally low fees.Exchange Product Name Ticker ISIN FeeSIX Swiss Exchange 21Shares Solana Core Staking ETP CSOL CH1385084384 0.35%Solana is one of the top blockchain networks powering innovation, and – due to its high-speed and low fees – Solana is expected to reach an all-time high in Total Locked Value (TLV) in 2025, with net inflows...

Hexagon Purus ASA: Invitation to the presentation of fourth quarter 2024 results

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Hexagon Purus ASA’s fourth quarter results 2024 will be released on 11 February 2025, 07:00 CET. Morten Holum (CEO) and Salman Alam (CFO) will present the results at 08:30 CET and the presentation will be broadcasted live via https://hexagonpurus.vivida.live. The presentation will be held in English and will be virtual. A recording of the presentation will be made available on www.hexagonpurus.com. For more information: Mathias Meidell, IR Director, Hexagon Purus ASATelephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com Salman Alam, CFO, Hexagon Purus ASA Telephone: +47 476 12 713 | salman.alam@hexagonpurus.com About Hexagon Purus ASA Hexagon Purus enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure cylinders and systems, battery systems and...

Month: January 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals